Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study.
暂无分享，去创建一个
T. Matsuda | Y. Kakehi | Y. Okada | O. Yoshida | T. Okabe | T. Tomoyoshi | Y. Arai | O. Mikami | S. Hida | T. Fukuyama